OAM
INSM icon

Oberweis Asset Management’s Insmed INSM Stock Holding History

Oberweis Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,600
Closed -$251K – 219
2018
Q2 		$251K Buy
+10,600
New +$273K 0.06% 206
2018
Q1 		– Sell
-10,000
Closed -$312K – 235
2017
Q4 		$312K Buy
10,000
+1,700
+20% +$50.2K 0.07% 202
2017
Q3 		$259K Buy
+8,300
New +$158K 0.07% 139

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Oberweis Asset Management's INSM Position: Q3 2018 in Review

Oberweis Asset Management sold out of Insmed (INSM) in Q3 2018, closing a stake of 10,600 shares — an estimated $251K sold.

Oberweis Asset Management first reported a position in INSM in Q3 2017 and held it in 3 quarters. The position peaked at $312K in Q4 2017. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

  • Oberweis Asset Management reported no remaining Insmed position as of Q3 2018 after selling out during the quarter.
  • Oberweis Asset Management sold 10,600 Insmed shares in Q3 2018, an estimated $251K.
  • Oberweis Asset Management first reported a position in Insmed in Q3 2017 and held it in 3 quarters.
  • Oberweis Asset Management's Insmed position peaked at $312K in Q4 2017.
  • 123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on Oberweis Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.